Platelet Response to Caplacizumab in the Treatment of Acquired Thrombotic Thrombocytopenic Purpura
Condition(s):Acquired Thrombotic Thrombocytopenic PurpuraLast Updated:May 30, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Acquired Thrombotic Thrombocytopenic PurpuraLast Updated:May 30, 2023Not yet recruiting
Condition(s):Idiopathic Thrombocytopenic PurpuraLast Updated:September 21, 2022Completed
Condition(s):PreeclampsiaLast Updated:August 17, 2022Active, not recruiting
Condition(s):Platelet FunctionLast Updated:June 13, 2022Active, not recruiting
Condition(s):Drug Interactions Between Clopidogrel and Serotonin Reuptake InhibitorsLast Updated:January 29, 2013Completed
Condition(s):Drug Interaction of ClopidogrelLast Updated:August 19, 2015Completed
Condition(s):Immune Thrombocytopenia (ITP)Last Updated:February 16, 2023Completed
Condition(s):Immune ThrombocytopeniaLast Updated:July 5, 2019Terminated
Condition(s):Idiopathic Thrombocytopenic Purpura; Thrombocytopenia; Thrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP); Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP); Thrombocytopenic Purpura; Immune ThrombocytopeniaLast Updated:February 9, 2017Completed
Condition(s):Wiskott-Aldrich SyndromeLast Updated:May 6, 2020Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.